ParkinsonCanadaV1, France, Analysis, clusterHead, KwdEn.cc(KwdEn.i)

Nombre de clusters :23

4	clinimetrics - rating scales
9	Pituitary adenylate cyclase activating peptide - Structure activity relation
3	Pardoprunox - partial dopamine agonist
28	Motor system disorder - evidence‐based medicine
11	Mood Disorders (etiology) - Quality of Life
8	Iron - Transferrin
3	Evoked Potentials, Motor (physiology) - Neuronal Plasticity (physiology)
7	Emotion emotionality - Face
6	Depression (etiology) - Postoperative Complications
8	Antiparkinson Agents (adverse effects) - Levodopa (adverse effects)
59	Female - Male
14	D3 Dopamine receptor - Primates
22	Cross-Over Studies - Time Factors
18	Parkinson Disease (psychology) - Quality of Life (psychology)
21	Dyskinesia - Levodopa
17	Mice, Inbred C57BL - Mutation (genetics)
108	Deep brain stimulation - deep brain stimulation
5	Dystonia - dystonia
13	Animal - Rat
19	Review - Depression
8	Animal model - Mouse
16	Anatomy - Brain (vertebrata)
18	Dementia - Medicine

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022

	La maladie de Parkinson au Canada (serveur d'exploration)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.